Abstract: Provided is an oral pharmaceutical composition with improved bioavailability and pharmacokinetic properties of a drug, by increasing a bioabsorption rate and an in vivo retention time of an active ingredient via intestine-targeted formulation of a particular naphthoquinone-based compound, or a pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, as an active ingredient.
Type:
Application
Filed:
November 26, 2007
Publication date:
March 11, 2010
Applicants:
MAZENCE INC., KT & G CP., LTD
Inventors:
In Geun Jo, Sang-Ku Yoo, Myung-gyu Park, Taehwan Kwak